Recombinant multi-species NEK2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NEK2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene. [provided by RefSeq, Feb 2011]
The Alternative Names of target: NEK2,Serine/threonine-protein kinase Nek2,HSPK 21, Never in mitosis A-related kinase 2 (NimA-related protein kinase 2), NimA-like protein kinase 1,NLK1,RP67,NEK2A,HsPK21,PPP1R111

Target products collectionGo to NEK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T49102-Ab-1/ GM-Tg-hg-T49102-Ab-2 Human NEK2 protein Human
GM-Tg-rg-T49102-Ab-1/ GM-Tg-rg-T49102-Ab-2 Rat NEK2 protein Rat
GM-Tg-mg-T49102-Ab-1/ GM-Tg-mg-T49102-Ab-2 Mouse NEK2 protein Mouse
GM-Tg-cynog-T49102-Ab-1/ GM-Tg-cynog-T49102-Ab-2 Cynomolgus/Rhesus macaque NEK2 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T49102-Ab-1/ GM-Tg-felg-T49102-Ab-2 Feline NEK2 protein Feline
GM-Tg-cang-T49102-Ab-1/ GM-Tg-cang-T49102-Ab-2 Canine NEK2 protein Canine
GM-Tg-bovg-T49102-Ab-1/ GM-Tg-bovg-T49102-Ab-2 Bovine NEK2 protein Bovine
GM-Tg-equg-T49102-Ab-1/ GM-Tg-equg-T49102-Ab-2 Equine NEK2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T49102-Ab-1/ GM-Tg-hg-T49102-Ab-2; GM-Tg-rg-T49102-Ab-1/ GM-Tg-rg-T49102-Ab-2;
GM-Tg-mg-T49102-Ab-1/ GM-Tg-mg-T49102-Ab-2; GM-Tg-cynog-T49102-Ab-1/ GM-Tg-cynog-T49102-Ab-2;
GM-Tg-felg-T49102-Ab-1/ GM-Tg-felg-T49102-Ab-2; GM-Tg-cang-T49102-Ab-1/ GM-Tg-cang-T49102-Ab-2;
GM-Tg-bovg-T49102-Ab-1/ GM-Tg-bovg-T49102-Ab-2; GM-Tg-equg-T49102-Ab-1/ GM-Tg-equg-T49102-Ab-2
Products Name NEK2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NEK2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NEK2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.